Market-Moving Exclusives

EXCLUSIVE: La Rosa Q3 Revenue Jumps 188%, CEO Eyes $100 Million Revenue Run Rate By 2024
EXCLUSIVE: Vision Marine Partners With Pontoon Manufacturer To Boost Electric Boating Solutions
EXCLUSIVE: Eco Wave Power Gets Green Light From US Army For First Onshore Wave Energy Project In LA
EXCLUSIVE: Vision Marine Partners With Pontoon Manufacturer To Boost Electric Boating Solutions
EXCLUSIVE: Eco Wave Power Gets Green Light From US Army For First Onshore Wave Energy Project In LA
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
EXCLUSIVE: Critical Metals Corp Advances Wolfsberg Lithium Project, Unveils New Drilling Approval and Saudi Plant Plans

Market-Moving Exclusives Recent News

EXCLUSIVE: Pineapple Adds Luxe Lending And Mortgage Magic, Eyes Strong Revenue Growth
Pineapple Financial Inc. (NYSE: PAPL) expands with two new affiliates, strengthening its position as a leader in the Canadian mortgage industry and utilizing AI and data-driven solutions for personalized options.
US Stocks May Cool As Trump Win-Fueled Rally Nears Potential Pause Amid Profit-Taking, Says Investment Bank: '...May Limit Further Upside'
Citigroup Inc. forecasts a blip in the ongoing stock market rally, which has been unfolding since the U.S. presidential elections. As per the strategists at Citigroup, the rally fueled by Donald Trump's return to the White House will lose steam as investors start to book profits.
EXCLUSIVE: OPAL Fuels Powers Up New Renewable Gas Facility at Polk County Landfill
OPAL announces commercial operations at RNG facility in Florida, providing cleaner fuel options and reducing emissions. Stock closed at $3.78.
EXCLUSIVE: Worksport Accelerates B2B Growth as Dealers Snap Up New AL4 Pre-Orders
Worksport Ltd (NASDAQ: WKSP) sees 200% growth in B2B sales as it launches pre-orders for the AL4 Premium Tonneau Cover, expanding dealer presence across the U.S. and Canada. Strong dealer demand and strategic display placements are driving significant sales momentum
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
NeuroSense Therapeutics schedules an FDA Type C meeting on Nov. 6 to finalize its Phase 3 trial design for PrimeC, a potential ALS treatment.
All Once Again Warned: Unregulated Cannabis Vapes Contain Dangerous Pesticides, Study Says
New study reveals 93% of illegal cannabis vapes are contaminated with harmful pesticides. THC levels far below what labels claim
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gains
Cannabis stocks rally as Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram show positive momentum. We look at resistance levels...
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer
Avalon GloboCare signs MOU with Qi Diagnostics to co-develop a nanosensor-based cannabis breathalyzer. Talks aim for a definitive deal in 120 days.
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
Cybin secures a U.S. patent for its CYB005 program targeting CNS disorders and prepares to launch a Phase 3 trial for CYB003 in major depressive disorder.
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID.
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
Adial Pharmaceuticals secures a new patent allowance for AD04, enhancing its precision medicine approach for treating alcohol use disorder. Topline results from AD04's latest study are expected in Q4 2024.
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
Nexalin Technology's clinical trial results highlight notable cognitive improvements in Alzheimer's patients using Deep Intracranial Frequency Stimulation technology. The study showed significant memory and cognition gains, increased hippocampal activity, and minimal side effects.
EXCLUSIVE: CleanCore's Eco-Friendly Products Roll Out At Knight-Swift Terminals, Aiming For Long-Term Recurring Revenue
CleanCore (NYSE: ZONE) partners with Knight-Swift (NYSE: KNX) to implement eco-friendly cleaning products, reducing carbon footprint and costs.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved